CARDURA XL

LOE Approaching

doxazosin mesylate

NDAORALTABLET, EXTENDED RELEASE
Approved
Feb 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1

Mechanism of Action

(BPH), such as urinary frequency, nocturia, weak stream, hesitancy, and incomplete emptying are related to two components, anatomical (static) and functional (dynamic). The static component is related to an increase in prostate size caused, in part, by a proliferation of smooth muscle cells in the…

Clinical Trials (1)

NCT01003886N/ACompleted

A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH)

Started May 2009
989 enrolled
Prostatic Hyperplasia